CHRONIC KIDNEY DISEASES
Clinical trials for CHRONIC KIDNEY DISEASES explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASES trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A common supplement may shield bones in kidney disease — a trial puts it to the test
Disease control TerminatedThis pilot trial investigates whether potassium citrate can improve bone quality and strength in adults and children with chronic kidney disease. Participants take either potassium citrate or a placebo for six months, along with blood and urine tests and advanced bone scans. The …
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: PHASE2, PHASE3 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a common diabetes drug protect the hearts of kidney patients?
Disease control TerminatedPeople with chronic kidney disease (CKD) often have an overactive sympathetic nervous system, which raises their risk of heart problems and death. This phase 4 trial tests whether pioglitazone, a drug usually used for diabetes, can reduce that nerve overactivity and improve blood…
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: PHASE4 • Sponsor: The University of Texas at Arlington • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can cutting carbs and a diabetes drug help kidneys?
Disease control TerminatedThis small pilot study tested whether a low-carb diet (50-100 grams of carbs per day) combined with the diabetes drug dapagliflozin could improve blood sugar control in people with chronic kidney disease and prediabetes or type 2 diabetes. Four participants were split into two gr…
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: NA • Sponsor: Department of Nephrology Clinic Ottakring Vienna • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New vitamin d pill aims to tame parathyroid glands in dialysis patients
Disease control TerminatedThis phase 2 study tested a weekly extended-release capsule of calcifediol (CTAP101) in 44 adults with chronic kidney disease on hemodialysis who also had vitamin D insufficiency and secondary hyperparathyroidism. The goal was to see if the drug could raise vitamin D levels and l…
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Aspirin study for kidney patients halted early – did the risks outweigh the benefits?
Disease control TerminatedThis study looked at whether taking a daily low-dose aspirin could help people with chronic kidney disease avoid their first heart attack or stroke. Over 4,600 participants were randomly assigned to take aspirin or receive usual care. The trial was stopped early, and the final re…
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: PHASE3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for Tough-to-Treat hypertension in kidney patients?
Disease control TerminatedThis study tested a drug called KBP-5074 in 652 adults with moderate-to-severe chronic kidney disease and high blood pressure that was not controlled by at least two other medications. Participants received either KBP-5074 or a placebo daily for up to 52 weeks to see if the drug …
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: PHASE3 • Sponsor: KBP Biosciences • Aim: Disease control
Last updated Jun 26, 2026 12:43 UTC
-
New home care model for kidney disease tested – no dialysis needed
Knowledge-focused TerminatedThis pilot study tested a home-based conservative care program for veterans with advanced chronic kidney disease who chose not to start dialysis. The program involved a team of doctors, nurses, and other specialists providing care at home. Only 2 participants were enrolled before…
Matched conditions: CHRONIC KIDNEY DISEASES
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC